Sampliner RE: Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1998, 93 (7): 1028-1032. 10.1111/j.1572-0241.1998.00362.x
Article
CAS
PubMed
Google Scholar
Axelrad AM, Fleischer DE: Esophageal tumors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Edited by: Feldman M, Scharschmidt BF, Sleisenger MH. 1998, 540-554. Philadelphia , W.B. Saunders Company.
Google Scholar
Drewitz DJ, Sampliner RE, Garewal HS: The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol. 1997, 92 (2): 212-215.
CAS
PubMed
Google Scholar
Nehra D, Howell P, Williams CP, Pye JK, Beynon J: Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut. 1999, 44 (5): 598-602.
Article
PubMed Central
CAS
PubMed
Google Scholar
Vaezi MF, Singh S, Richter JE: Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology. 1995, 108 (6): 1897-1907. 10.1016/0016-5085(95)90156-6
Article
CAS
PubMed
Google Scholar
Goldstein SR, Yang GY, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL, Yang CS: Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis. 1997, 18 (11): 2265-2270. 10.1093/carcin/18.11.2265
Article
CAS
PubMed
Google Scholar
Nishijima K, Miwa K, Miyashita T, Kinami S, Ninomiya I, Fushida S, Fujimura T, Hattori T: Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg. 2004, 240 (1): 57-67. 10.1097/01.sla.0000130850.31178.8c
Article
PubMed Central
PubMed
Google Scholar
van der Woude CJ, Jansen PL, Tiebosch AT, Beuving A, Homan M, Kleibeuker JH, Moshage H: Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype. Hum Pathol. 2002, 33 (7): 686-692. 10.1053/hupa.2002.124908
Article
CAS
PubMed
Google Scholar
Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B: Identification of a nuclear receptor for bile acids. Science. 1999, 284 (5418): 1362-1365. 10.1126/science.284.5418.1362
Article
CAS
PubMed
Google Scholar
Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ: Vitamin D receptor as an intestinal bile acid sensor. Science. 2002, 296 (5571): 1313-1316. 10.1126/science.1070477
Article
CAS
PubMed
Google Scholar
Repa JJ, Mangelsdorf DJ: The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol. 2000, 16: 459-481. 10.1146/annurev.cellbio.16.1.459
Article
CAS
PubMed
Google Scholar
De Gottardi A, Touri F, Maurer CA, Perez A, Maurhofer O, Ventre G, Bentzen CL, Niesor EJ, Dufour JF: The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig Dis Sci. 2004, 49 (6): 982-989. 10.1023/B:DDAS.0000034558.78747.98
Article
CAS
PubMed
Google Scholar
Shishodia S, Aggarwal BB: Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem. 2004, 279 (45): 47148-47158. 10.1074/jbc.M408093200
Article
CAS
PubMed
Google Scholar
Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005, 26 (5): 662-687. 10.1210/er.2004-0002
Article
CAS
PubMed
Google Scholar
Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W, Yan B: Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys. 1999, 368 (1): 14-22. 10.1006/abbi.1999.1307
Article
CAS
PubMed
Google Scholar
Huber RM, Murphy K, Miao B, Link JR, Cunningham MR, Rupar MJ, Gunyuzlu PL, Haws TF, Kassam A, Powell F, Hollis GF, Young PR, Mukherjee R, Burn TC: Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene. 2002, 290 (1-2): 35-43. 10.1016/S0378-1119(02)00557-7
Article
CAS
PubMed
Google Scholar
Niesor EJ, Flach J, Lopes-Antoni I, Perez A, Bentzen CL: The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases. Curr Pharm Des. 2001, 7 (4): 231-259. 10.2174/1381612013398185
Article
CAS
PubMed
Google Scholar
Katada N, Hinder RA, Smyrk TC, Hirabayashi N, Perdikis G, Lund RJ, Woodward T, Klingler PJ: Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus. Arch Surg. 1997, 132 (7): 728-733.
Article
CAS
PubMed
Google Scholar
Dvorakova K, Payne CM, Ramsey L, Bernstein H, Holubec H, Chavarria M, Bernstein C, Sampliner RE, Riley C, Prasad A, Garewal H: Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues. Am J Gastroenterol. 2005, 100 (2): 424-431. 10.1111/j.1572-0241.2005.40932.x
Article
PubMed
Google Scholar
Morales CP, Souza RF, Spechler SJ: Hallmarks of cancer progression in Barrett's oesophagus. Lancet. 2002, 360 (9345): 1587-1589. 10.1016/S0140-6736(02)11569-8
Article
PubMed
Google Scholar
Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, Gonzalez FJ, Heyman RA, Mangelsdorf DJ, Moore DD: A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 2002, 296 (5573): 1703-1706. 10.1126/science.1072891
Article
CAS
PubMed
Google Scholar
Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, Cheng CC, Zink RW, Barr RJ, Hepler CD, Krishnan V, Bullock HA, Burris LL, Galvin RJ, Bramlett K, Stayrook KR: The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand. Mol Pharmacol. 2005, 67 (3): 948-954. 10.1124/mol.104.007054
Article
CAS
PubMed
Google Scholar
Alberts DS, Hallum AV, Stratton-Custis M, Garcia DJ, Gleason-Guzman M, Salmon SE, Santabarbara P, Niesor EJ, Floret S, Bentzen CL: Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug. Clin Cancer Res. 2001, 7 (5): 1246-1250.
CAS
PubMed
Google Scholar
Bishop-Bailey D, Walsh DT, Warner TD: Expression and activation of the farnesoid X receptor in the vasculature. Proc Natl Acad Sci U S A. 2004, 101 (10): 3668-3673. 10.1073/pnas.0400046101
Article
PubMed Central
CAS
PubMed
Google Scholar
Pera M, Trastek VF, Carpenter HA, Fernandez PL, Cardesa A, Mohr U, Pairolero PC: Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg. 1993, 55 (6): 1386-92; discussion 1392-3.
Article
CAS
PubMed
Google Scholar
Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999, 340 (11): 825-831. 10.1056/NEJM199903183401101
Article
CAS
PubMed
Google Scholar
Palanca-Wessels MC, Klingelhutz A, Reid BJ, Norwood TH, Opheim KE, Paulson TG, Feng Z, Rabinovitch PS: Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis. 2003, 24 (7): 1183-1190. 10.1093/carcin/bgg076
Article
CAS
PubMed
Google Scholar
de Both NJ, Wijnhoven BP, Sleddens HF, Tilanus HW, Dinjens WN: Establishment of cell lines from adenocarcinomas of the esophagus and gastric cardia growing in vivo and in vitro. Virchows Arch. 2001, 438 (5): 451-456. 10.1007/s004280000358
Article
CAS
PubMed
Google Scholar
Philpott NJ, Turner AJ, Scopes J, Westby M, Marsh JC, Gordon-Smith EC, Dalgleish AG, Gibson FM: The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood. 1996, 87 (6): 2244-2251.
CAS
PubMed
Google Scholar